Atiprimod |
|
MTT Assay |
10.00 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
Huh-7 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
10.00 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
HepG2 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
10.00 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
HepG2.2.15 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
10.00 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
AD38 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
10.00 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
G64 |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
10.00 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
5.00 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
2.50 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
1.25 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.62 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
|
MTT Assay |
0.32 µM |
T cells |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.20 µM |
FDCP-EpoR JAK2WT |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.40 µM |
FDCP-EpoR JAK2WT |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.60 µM |
FDCP-EpoR JAK2WT |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.80 µM |
FDCP-EpoR JAK2WT |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.20 µM |
FDCP-EpoR JAK2V617F |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.40 µM |
FDCP-EpoR JAK2V617F |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.60 µM |
FDCP-EpoR JAK2V617F |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell proliferation |
MTT Assay |
0.80 µM |
FDCP-EpoR JAK2V617F |
Mus musculus |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
MM-1 |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
MM-1 |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
MM-1 |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
MM-1 |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
U266-B1 |
Homo sapiens |
|
|
|